Juchnicka, I.; Kuźmicki, M.; Zabielski, P.; Krętowski, A.; Błachnio-Zabielska, A.; Szamatowicz, J.
Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes. J. Clin. Med. 2022, 11, 384.
https://doi.org/10.3390/jcm11020384
AMA Style
Juchnicka I, Kuźmicki M, Zabielski P, Krętowski A, Błachnio-Zabielska A, Szamatowicz J.
Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes. Journal of Clinical Medicine. 2022; 11(2):384.
https://doi.org/10.3390/jcm11020384
Chicago/Turabian Style
Juchnicka, Ilona, Mariusz Kuźmicki, Piotr Zabielski, Adam Krętowski, Agnieszka Błachnio-Zabielska, and Jacek Szamatowicz.
2022. "Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes" Journal of Clinical Medicine 11, no. 2: 384.
https://doi.org/10.3390/jcm11020384
APA Style
Juchnicka, I., Kuźmicki, M., Zabielski, P., Krętowski, A., Błachnio-Zabielska, A., & Szamatowicz, J.
(2022). Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes. Journal of Clinical Medicine, 11(2), 384.
https://doi.org/10.3390/jcm11020384